Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany ; day:21 ; month:8 ; year:2023 ; pages:1-10
Clinical research in cardiology ; (21.8.2023), 1-10
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-023-02257-6
- URN
-
urn:nbn:de:101:1-2023110607471218684452
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koenig, Wolfgang
- Lorenz, Elke S.
- Beier, Lea
- Gouni-Berthold, Ioanna
- SpringerLink (Online service)
Other Objects (12)
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Initial non-adherence to lipid-lowering medication: a systematic literature review
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Initial non-adherence to lipid-lowering medication: a systematic literature review
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Initial non-adherence to lipid-lowering medication: a systematic literature review
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention